An Unusual Presentation of Severe Hypothyroidism in a Child With Undiagnosed Systemic Lupus Erythematous
Open Access
- 3 December 2025
- journal article
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 4 (1)
Abstract
Myxedema is increasingly rare in the United Kingdom, particularly among patients already on treatment. We present a case of a 13-year-old girl diagnosed with autoimmune hypothyroidism who was started on 75 µg of levothyroxine by her general practitioner. She was referred to the endocrine clinic after 6 months of treatment for hypothyroidism with 2 months of worsening fatigue, chest pain, peripheral edema, and dyspnea. On hospitalization, the patient’s laboratory tests revealed undetectable free thyroxine level (fT4) and elevated thyrotropin (TSH) greater than 500 μIU/mL (SI: >500 m mIU/L) (reference range, 0.51-4.30 μIU/mL [SI: 0.51-4.30 mIU/L]). She was diagnosed with thyroid myxedema and commenced intravenous (IV) hydrocortisone, IV maintenance fluids, and antibiotics. However, the constellation of signs and symptoms remained perplexing. Further tests revealed a large pericardial effusion, deep vein thrombosis, and nephritis. A multidisciplinary approach confirmed the diagnosis of systemic lupus erythematous (SLE), and the patient was successfully started on rituximab therapy within 5 days of admission. This case illustrates the importance of considering potential underlying diagnoses when assessing patients with hypothyroid crisis, especially when symptoms deviate from the typical clinical presentation. The timely recognition and management of this patient's underlying SLE were crucial in her recovery.Keywords
Funding Information
- NIHR (NIHR304587)
- NIHR (ACF-2023-09-004)
This publication has 19 references indexed in Scilit:
- Levothyroxine Treatment and the Risk of Cardiac Arrhythmias – Focus on the Patient Submitted to Thyroid SurgeryFrontiers in Endocrinology, 2021
- Hypothyroidism in Context: Where We’ve Been and Where We’re GoingAdvances in Therapy, 2019
- Initiation of levothyroxine in a patient with hypothyroidism inducing adrenal crisis requiring VA ECMO: a tale of preventable disasterBMJ Case Reports, 2019
- StatPearls2019
- Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysisLupus, 2018
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone ReplacementThyroid®, 2014
- Hypercoagulability and Nephrotic SyndromeCurrent Vascular Pharmacology, 2014
- IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cellsJournal of Clinical Investigation, 2011
- Thyroid Disorders and HypercoagulabilitySeminars in Thrombosis and Hemostasis, 2011
- Mechanisms behind the non-thyroidal illness syndrome: an updateJournal of Endocrinology, 2009